SCHEMBL7973626

SCHEMBL7973626

Oc1nc(-c2cccc(Cl)c2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ GLA P06280 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ UBE2N P61088 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ ACP1 P24666 1/20 0.43
▸ YTHDC1 Q96MU7 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ EGLN1 Q9GZT9 1/20 0.41
▸ HTR6 P50406 1/20 0.40
▸ FSCN1 Q16658 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CNR2 P34972 1/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974012 0.95 ALDH1A1 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991646 0.94 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988668 0.94 SMN1; SMN2 (0.44) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991566 0.93 ACP1 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7987310 0.92 YTHDC1 (0.41) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7975240 0.92 ALDH1A1 (0.42) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7985360 0.92 POLB (0.40) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988781 0.90 MET (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7974267 0.90 SMN1; SMN2 (0.43) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7991597 0.90 PDE4B (0.39) SMN1; SMN2GLAHTTUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback